ESGO/ESTRO Quality Indicators for Radiation Therapy for Cervical Cancer – with Cyrus Chargari and Christina Fotopoulou

In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Cyrus Chargari and Christina Fotopoulou to discuss the ESGO/ESTRO quality indicators for radiation therapy for cervical cancer. Dr. Chargari is a radiation oncologist at Pitié Salpêtrière University Hospital – Sorbonne University, Paris, France. He is full professor of oncology and serves as the Secretary-General of the French Society of Radiation Oncology. He is an active member of ESTRO. Dr. Fotopoulou is the Chair of Gynaecological Cancer Surgery at the Department of Surgery and Cancer at Imperial College London, UK. She has served as an elected ESGO council member and Chair of the ESGO and BGCS guidelines committee.   Highlights: Multidisciplinary quality indicators jointly with ESGO and ESTRO about the radiotherapeutic management of cervical cancer. The objective was to provide practitioners and administrators with quantifiable metrics for enhancing clinical care and organizational processes, particularly considering the complexities of modern radiotherapy techniques. The indicators were established through a combination of scientific evidence and expert consensus. The development process involved literature review, expert meetings, validation, and external review by clinicians. The resulting set of 19 indicators covers pre-treatment, treatment, and outcomes, and aims to standardize radiation therapy quality, with the next step being the accreditation of centers for cervical cancer management in the quality assurance process.